Advanced search
Publication Cover
Molecular and Cellular Biology Volume 28, 2008 - Issue 9
Submit an article Journal homepage
38
Views
137
CrossRef citations to date
0
Altmetric
Article

Biphasic Response of Pancreatic β-Cell Mass to Ablation of Tuberous Sclerosis Complex 2 in Mice

Yutaka Shigeyama1 Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe650-0017, Japan
,
Toshiyuki Kobayashi2 Department of Experimental Pathology
,
Yoshiaki Kido1 Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe650-0017, JapanCorrespondence[email protected]
,
Naoko Hashimoto1 Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe650-0017, Japan
,
Shun-ichiro Asahara1 Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe650-0017, Japan
,
Tomokazu Matsuda1 Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe650-0017, Japan
,
Akihiko Takeda1 Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe650-0017, Japan
,
Tae Inoue1 Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe650-0017, Japan
,
Yuki Shibutani1 Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe650-0017, Japan
,
Maki Koyanagi1 Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe650-0017, Japan
,
Tohru Uchida1 Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe650-0017, Japan
,
Maki Inoue3 Department of Cell Biology, Cancer Institute, Japanese Foundation of Cancer Research, Tokyo135-8550, Japan
,
Okio Hino2 Department of Experimental Pathology
,
Masato Kasuga1 Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe650-0017, Japan
&
Tetsuo Noda3 Department of Cell Biology, Cancer Institute, Japanese Foundation of Cancer Research, Tokyo135-8550, Japan
 show all
Pages 2971-2979 | Received 14 Sep 2007, Accepted 15 Feb 2008, Published online: 27 Mar 2023

Citations (137)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Zofia Chrienova, Eugenie Nepovimova & Kamil Kuca. (2021) The role of mTOR in age-related diseases. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1678-1692.
Read now
Yumi Aizawa, Tomomi Shirai, Toshiyuki Kobayashi, Okio Hino, Yoshimasa Tsujii, Hirofumi Inoue, Machiko Kazami, Tadahiro Tadokoro, Tsukasa Suzuki, Ken-Ichi Kobayashi & Yuji Yamamoto. (2016) Metabolic abnormalities induced by mitochondrial dysfunction in skeletal muscle of the renal carcinoma Eker (TSC2+/−) rat model. Bioscience, Biotechnology, and Biochemistry 80:8, pages 1513-1519.
Read now
Jia Nie, Xiao Han & Yuguang Shi. (2013) SAD-A and AMPK kinases: The “yin and yang” regulators of mTORC1 signaling in pancreatic β cells. Cell Cycle 12:21, pages 3366-3369.
Read now
Victoria Tsai & Peter B Crino. (2012) Tuberous sclerosis complex: genetic basis and management strategies. Advances in Genomics and Genetics 2, pages 19-31.
Read now
Alberto Bartolome, Carlos Guillen & Manuel Benito. (2012) Autophagy plays a protective role in endoplasmic reticulum stress-mediated pancreatic β cell death. Autophagy 8:12, pages 1757-1768.
Read now
Manuel Blandino-Rosano, Angela Y. Chen, Joshua O. Scheys, Emilyn U. Alejandro, Aaron P. Gould, Tatyana Taranukha, Lynda Elghazi, Corentin Cras-Méneur & Ernesto Bernal-Mizrachi. (2012) mTORC1 signaling and regulation of pancreatic β-cell mass. Cell Cycle 11:10, pages 1892-1902.
Read now
Emmani B.M. Nascimento & D. Margriet Ouwens. (2009) PRAS40: Target or modulator of mTORC1 signalling and insulin action?. Archives of Physiology and Biochemistry 115:4, pages 163-175.
Read now

Articles from other publishers (130)

Masako Seike, Shun-ichiro Asahara, Hiroyuki Inoue, Michiyo Kudo, Ayumi Kanno, Aisha Yokoi, Hirotaka Suzuki, Maki Kimura-Koyanagi, Yoshiaki Kido & Wataru Ogawa. (2023) l-Asparaginase regulates mTORC1 activity via a TSC2-dependent pathway in pancreatic beta cells. Biochemical and Biophysical Research Communications 652, pages 121-130.
Crossref
Violina Kakoty, Sarathlal KC, Shobha Kumari, Chih-Hao Yang, Sunil Kumar Dubey, Amirhossein Sahebkar, Prashant Kesharwani & Rajeev Taliyan. (2023) Brain insulin resistance linked Alzheimer’s and Parkinson’s disease pathology: An undying implication of epigenetic and autophagy modulation. Inflammopharmacology 31:2, pages 699-716.
Crossref
Sylwester M. Kloska, Krzysztof Pałczyński, Tomasz Marciniak, Tomasz Talaśka, Marissa Miller, Beata J. Wysocki, Paul H. Davis, Ghada A. Soliman & Tadeusz A. Wysocki. (2022) Queueing theory model of mTOR complexes’ impact on Akt-mediated adipocytes response to insulin. PLOS ONE 17:12, pages e0279573.
Crossref
Tiago Bordeira Gaspar, José Manuel Lopes, Paula Soares & João Vinagre. (2022) An update on genetically engineered mouse models of pancreatic neuroendocrine neoplasms. Endocrine-Related Cancer 29:12, pages R191-R208.
Crossref
Chengan Lv, Yuchen Sun, Zhe Yu Zhang, Zeyad Aboelela, Xinyuan Qiu & Zhuo-Xian Meng. (2022) β- cell dynamics in type 2 diabetes and in dietary and exercise interventions . Journal of Molecular Cell Biology 14:7.
Crossref
Takayoshi Sasako, Toshihiro Umehara, Kotaro Soeda, Kazuma Kaneko, Miho Suzuki, Naoki Kobayashi, Yukiko Okazaki, Miwa Tamura-Nakano, Tomoki Chiba, Domenico Accili, C. Ronald Kahn, Tetsuo Noda, Hiroshi Asahara, Toshimasa Yamauchi, Takashi Kadowaki & Kohjiro Ueki. (2022) Deletion of skeletal muscle Akt1/2 causes osteosarcopenia and reduces lifespan in mice. Nature Communications 13:1.
Crossref
Mohammad Sherafati-Moghadam, Hamed Alizadeh Pahlavani, Farhad Daryanoosh & Mohsen Salesi. (2022) The effect of high-intensity interval training (HIIT) on protein expression in Flexor Hallucis Longus (FHL) and soleus (SOL) in rats with type 2 diabetes. Journal of Diabetes & Metabolic Disorders 21:2, pages 1499-1508.
Crossref
Ghada A. Soliman, Rinat R. Abzalimov & Ye He. (2022) mTORC1 and mTORC2 Complexes Regulate the Untargeted Metabolomics and Amino Acid Metabolites Profile through Mitochondrial Bioenergetic Functions in Pancreatic Beta Cells. Nutrients 14:15, pages 3022.
Crossref
Lin Yang, Zhixin Zhang, Doudou Wang, Yu Jiang & Ying Liu. (2022) Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications. Current Drug Targets 23:7, pages 692-710.
Crossref
Nikos Koundouros & John Blenis. (2022) Targeting mTOR in the Context of Diet and Whole-body Metabolism. Endocrinology 163:6.
Crossref
Shun-ichiro Asahara, Hiroyuki Inoue, Hitoshi Watanabe & Yoshiaki Kido. (2022) Roles of mTOR in the Regulation of Pancreatic β-Cell Mass and Insulin Secretion. Biomolecules 12:5, pages 614.
Crossref
Shun-ichiro Asahara, Hiroyuki Inoue & Yoshiaki Kido. (2022) Regulation of Pancreatic β-Cell Mass by Gene-Environment Interaction. Diabetes & Metabolism Journal 46:1, pages 38-48.
Crossref
Richa Aggarwal, Zhechu Peng, Ni Zeng, Joshua Silva, Lina He, Jingyu Chen, Anketse Debebe, Taojian Tu, Mario Alba, Chien-Yu Chen, Eileen X. Stiles, Handan Hong & Bangyan L. Stiles. (2022) Chronic Exposure to Palmitic Acid Down-Regulates AKT in Beta-Cells through Activation of mTOR. The American Journal of Pathology 192:1, pages 130-145.
Crossref
R. Dhanya & C. C. Kartha. (2021) Quercetin improves oxidative stress-induced pancreatic beta cell alterations via mTOR-signaling. Molecular and Cellular Biochemistry 476:11, pages 3879-3887.
Crossref
Jacob Bar-Tana. (2021) Insulin Resistance, Secretion and Clearance –Taming the Three Effector Encounter of Type 2 Diabetes. Frontiers in Endocrinology 12.
Crossref
Anthony M. Kyriakopoulos & Peter A. McCullough. (2021) Synthetic mRNAs; Their Analogue Caps and Contribution to Disease. Diseases 9:3, pages 57.
Crossref
Ting Yuan, Karthika Annamalai, Shruti Naik, Blaz Lupse, Shirin Geravandi, Anasua Pal, Aleksandra Dobrowolski, Jaee Ghawali, Marina Ruhlandt, Kanaka Durga Devi Gorrepati, Zahra Azizi, Dae-Sik Lim, Kathrin Maedler & Amin Ardestani. (2021) The Hippo kinase LATS2 impairs pancreatic β-cell survival in diabetes through the mTORC1-autophagy axis. Nature Communications 12:1.
Crossref
Jesús Burillo, Patricia Marqués, Beatriz Jiménez, Carlos González-Blanco, Manuel Benito & Carlos Guillén. (2021) Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease. Cells 10:5, pages 1236.
Crossref
Alberto Bartolomé & Utpal B Pajvani. (2021) MTOR and Beta Cell Adaptation in T2D. The Journal of Clinical Endocrinology & Metabolism 106:3, pages e1466-e1467.
Crossref
Bas BrouwersIlaria Coppola, Katlijn Vints, Bastian Dislich, Nathalie Jouvet, Leentje Van Lommel, Charlotte Segers, Natalia V. Gounko, Lieven Thorrez, Frans Schuit, Stefan F. Lichtenthaler, Jennifer L. Estall, Jeroen Declercq, Bruno Ramos-Molina & John W.M. Creemers. (2021) Loss of Furin in β-Cells Induces an mTORC1-ATF4 Anabolic Pathway That Leads to β-Cell Dysfunction . Diabetes 70:2, pages 492-503.
Crossref
Xiaoming Hu & Feifan Guo. (2021) Amino Acid Sensing in Metabolic Homeostasis and Health. Endocrine Reviews 42:1, pages 56-76.
Crossref
Hiroyuki Inoue, Shun-ichiro Asahara, Yumiko Sugiura, Yukina Kawada, Asuka Imai, Chisako Hara, Ayumi Kanno, Maki Kimura-Koyanagi & Yoshiaki Kido. (2021) Histone deacetylase 6 regulates insulin signaling in pancreatic β cells. Biochemical and Biophysical Research Communications 534, pages 896-901.
Crossref
Jacob Bar-Tana. (2020) Type 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm. Reviews in Endocrine and Metabolic Disorders 21:4, pages 613-629.
Crossref
Jiao Li, Yanpeng Zhang, Xu-Fang Liang, Shan He, Shulin Tang, Ling Li & Xu Chen. (2020) mTOR - Mediated protein synthesis by inhibiting protein catabolism in Chinese perch (Siniperca chuatsi). Biochemical and Biophysical Research Communications 533:1, pages 23-29.
Crossref
Ghada A. Soliman & C. Mary Schooling. (2020) Causal association between mTOR-dependent EIF-4E and EIF-4A circulating protein levels and type 2 diabetes: a Mendelian randomization study. Scientific Reports 10:1.
Crossref
Takenori Kotani, Jajar Setiawan, Tasuku Konno, Noriko Ihara, Saki Okamoto, Yasuyuki Saito, Yoji Murata, Tetsuo Noda & Takashi Matozaki. (2020) Regulation of colonic epithelial cell homeostasis by mTORC1. Scientific Reports 10:1.
Crossref
Sebastian Maciak, Diana Sawicka, Anna Sadowska, Sławomir Prokopiuk, Sylwia Buczyńska, Marek Bartoszewicz, Gabriela Niklińska, Marek Konarzewski & Halina Car. (2020) Low basal metabolic rate as a risk factor for development of insulin resistance and type 2 diabetes. BMJ Open Diabetes Research & Care 8:1, pages e001381.
Crossref
Fang Yang, Yang Chen, Zhiqiang Xue, Yaogai Lv, Li Shen, Kexin Li, Pingping Zheng, Pan Pan, Tianyu Feng, Lina Jin & Yan Yao. (2020) High-Throughput Sequencing and Exploration of the lncRNA-circRNA-miRNA-mRNA Network in Type 2 Diabetes Mellitus. BioMed Research International 2020, pages 1-13.
Crossref
Ayumi Kanno, Shun-ichiro Asahara, Ayuko Furubayashi, Katsuhisa Masuda, Risa Yoshitomi, Emi Suzuki, Tomoko Takai, Maki Kimura-Koyanagi, Tomokazu Matsuda, Alberto Bartolome, Yushi Hirota, Norihide Yokoi, Yuka Inaba, Hiroshi Inoue, Michihiro Matsumoto, Kenichi Inoue, Takaya Abe, Fan-Yan Wei, Kazuhito Tomizawa, Wataru Ogawa, Susumu Seino, Masato Kasuga & Yoshiaki Kido. (2020) GCN2 regulates pancreatic β cell mass by sensing intracellular amino acid levels. JCI Insight 5:9.
Crossref
Aharon Helman, Andrew L. Cangelosi, Jeffrey C. Davis, Quan Pham, Arielle Rothman, Aubrey L. Faust, Juerg R. Straubhaar, David M. Sabatini & Douglas A. Melton. (2020) A Nutrient-Sensing Transition at Birth Triggers Glucose-Responsive Insulin Secretion. Cell Metabolism 31:5, pages 1004-1016.e5.
Crossref
Wakiko Iwata, Hiroyuki Unoki-Kubota, Hideki Kato, Akira Shimizu, Michihiro Matsumoto, Toshiyuki Imasawa, Arisa Igarashi, Kenji Matsumoto, Tetsuo Noda, Yasuo Terauchi, Masaomi Nangaku, Masato Kasuga & Yasushi Kaburagi. (2020) Podocyte-specific deletion of tubular sclerosis complex 2 promotes focal segmental glomerulosclerosis and progressive renal failure. PLOS ONE 15:3, pages e0229397.
Crossref
Courtney Zasha Rumala, Juan Liu, Jason Wei Locasale, Barbara Ellen Corkey, Jude Thaddeus Deeney & Lucia Egydio Rameh. (2020) Exposure of Pancreatic β-Cells to Excess Glucose Results in Bimodal Activation of mTORC1 and mTOR-Dependent Metabolic Acceleration. iScience 23:2, pages 100858.
Crossref
Dan He, Hongguang Wu, Jinnan Xiang, Xinsen Ruan, Peike Peng, Yuanyuan Ruan, Ye-Guang Chen, Yibin Wang, Qiang Yu, Hongbing Zhang, Samy L. Habib, Ronald A. De Pinho, Huijuan Liu & Baojie Li. (2020) Gut stem cell aging is driven by mTORC1 via a p38 MAPK-p53 pathway. Nature Communications 11:1.
Crossref
Bodo C. Melnik. (2019) Milk exosomal miRNAs: potential drivers of AMPK-to-mTORC1 switching in β-cell de-differentiation of type 2 diabetes mellitus. Nutrition & Metabolism 16:1.
Crossref
John A. Kubi, Andy C.H. Chen, Sze Wan Fong, Keng Po Lai, Chris K.C. Wong, William S.B. Yeung, Kai Fai Lee & Yin Lau Lee. (2019) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the differentiation of embryonic stem cells towards pancreatic lineage and pancreatic beta cell function. Environment International 130, pages 104885.
Crossref
Rami Jaafar, Stella Tran, Ajit N. Shah, Gao Sun, Martin Valdearcos, Piero Marchetti, Matilde Masini, Avital Swisa, Simone Giacometti, Ernesto Bernal-Mizrachi, Aleksey Matveyenko, Matthias Hebrok, Yuval Dor, Guy A. Rutter, Suneil K. Koliwad & Anil Bhushan. (2019) mTORC1-to-AMPK switching underlies β cell metabolic plasticity during maturation and diabetes. Journal of Clinical Investigation 129:10, pages 4124-4137.
Crossref
Mikhail V. Blagosklonny. (2019) Fasting and rapamycin: diabetes versus benevolent glucose intolerance. Cell Death & Disease 10:8.
Crossref
Yali Tuo & Ming Xiang. (2019) mTOR: A double-edged sword for diabetes. Journal of Leukocyte Biology 106:2, pages 385-395.
Crossref
Ayumi Kanno, Shun‐ichiro Asahara, Mao Kawamura, Ayuko Furubayashi, Shoko Tsuchiya, Emi Suzuki, Tomoko Takai, Maki Koyanagi‐Kimura, Tomokazu Matsuda, Yuko Okada, Wataru Ogawa & Yoshiaki Kido. (2018) Early administration of dapagliflozin preserves pancreatic β‐cell mass through a legacy effect in a mouse model of type 2 diabetes. Journal of Diabetes Investigation 10:3, pages 577-590.
Crossref
Xiaocen Chang, Linna Suo, Na Xu & Yuyan Zhao. (2019) Orexin-A Stimulates Insulin Secretion Through the Activation of the OX1 Receptor and Mammalian Target of Rapamycin in Rat Insulinoma Cells. Pancreas 48:4, pages 568-573.
Crossref
Yassine El HianiEmmanuel Eroume-A EgomXian-Ping Dong. (2019) mTOR signalling: jack-of-all-trades. Biochemistry and Cell Biology 97:1, pages 58-67.
Crossref
Alpana Mukhuty, Chandrani Fouzder, Snehasis Das & Dipanjan Chattopadhyay. 2019. Type 2 Diabetes [Working Title]. Type 2 Diabetes [Working Title].
Beth Levine & Guido Kroemer. (2019) Biological Functions of Autophagy Genes: A Disease Perspective. Cell 176:1-2, pages 11-42.
Crossref
Hanyu Liang, Jia Nie, Candice E. Van Skike, Joseph M. Valentine & Miranda E. Orr. 2019. Diabetes Mellitus. Diabetes Mellitus 185 225 .
Yael Riahi, Tal Israeli, Roni Yeroslaviz, Shoshana Chimenez, Dana Avrahami, Miri Stolovich-Rain, Ido Alter, Marina Sebag, Nava Polin, Ernesto Bernal-Mizrachi, Yuval Dor, Erol Cerasi & Gil Leibowitz. (2018) Inhibition of mTORC1 by ER stress impairs neonatal β-cell expansion and predisposes to diabetes in the Akita mouse. eLife 7.
Crossref
Carlos Guillén & Manuel Benito. (2018) mTORC1 Overactivation as a Key Aging Factor in the Progression to Type 2 Diabetes Mellitus. Frontiers in Endocrinology 9.
Crossref
Benjamin Bouillet, Perrine Buffier, Sarra Smati, Françoise Archambeaud, Bertrand Cariou & Bruno Vergès. (2018) Expert opinion on the metabolic complications of mTOR inhibitors. Annales d'Endocrinologie 79:5, pages 583-590.
Crossref
Nathan Duval, Guido N. Vacano & David Patterson. (2018) Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging. Frontiers in Aging Neuroscience 10.
Crossref
Gergő Mészáros, Adrien Pasquier, Kevin Vivot, Alexander Goginashvili & Romeo Ricci. (2018) Lysosomes in nutrient signalling: A focus on pancreatic β-cells. Diabetes, Obesity and Metabolism 20, pages 104-115.
Crossref
Juan Sun, Liqun Mao, Hongyan Yang & Decheng Ren. (2018) Critical role for the Tsc1-mTORC1 pathway in β-cell mass in Pdx1-deficient mice. Journal of Endocrinology 238:2, pages 151-163.
Crossref
Danielle N. Kling, Leandro D. Teixeira, Evon M. DeBose-Scarlett & Claudio F. Gonzalez. 2018. Probiotics - Current Knowledge and Future Prospects. Probiotics - Current Knowledge and Future Prospects.
Stefano Benedini, Federica Ermetici, Silvia Briganti, Roberto Codella, Ileana Terruzzi, Paola Maffi, Rossana Caldara, Antonio Secchi, Rita Nano, Lorenzo Piemonti, Rodolfo Alejandro, Camillo Ricordi & Livio Luzi. (2018) Insulin-mimetic effects of short-term rapamycin in type 1 diabetic patients prior to islet transplantation. Acta Diabetologica 55:7, pages 715-722.
Crossref
Miriam García Hernández, Ana García Aguilar, Jesús Burillo, Raquel Gómez Oca, Maria Antonietta Manca, Ana Novials, Gema Alcarraz-Vizan, Carlos Guillén & Manuel Benito. (2018) Pancreatic β cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics. Cell Death & Disease 9:5.
Crossref
J.H. McDermott, N. Hickson, I. Banerjee, P.G. Murray, D. Ram, K. Metcalfe, J. Clayton-Smith & S. Douzgou. (2018) Hypoglycaemia represents a clinically significant manifestation of PIK3CA - and CCND2 -associated segmental overgrowth . Clinical Genetics 93:3, pages 687-692.
Crossref
Ting Yuan, Blaz Lupse, Kathrin Maedler & Amin Ardestani. (2018) mTORC2 Signaling: A Path for Pancreatic β Cell's Growth and Function. Journal of Molecular Biology 430:7, pages 904-918.
Crossref
Fei Yang, Lingli Yang, Mari Wataya-Kaneda, Takuji Yoshimura, Atsushi Tanemura & Ichiro Katayama. (2018) Uncoupling of ER/Mitochondrial Oxidative Stress in mTORC1 Hyperactivation-Associated Skin Hypopigmentation. Journal of Investigative Dermatology 138:3, pages 669-678.
Crossref
Jillian L. Rourke, Queenie Hu & Robert A. Screaton. (2018) AMPK and Friends: Central Regulators of β Cell Biology. Trends in Endocrinology & Metabolism 29:2, pages 111-122.
Crossref
Amin Ardestani, Blaz Lupse, Yoshiaki Kido, Gil Leibowitz & Kathrin Maedler. (2018) mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells. Cell Metabolism 27:2, pages 314-331.
Crossref
Yukina Kawada, Shun-ichiro Asahara, Yumiko Sugiura, Ayaka Sato, Ayuko Furubayashi, Mao Kawamura, Alberto Bartolome, Emi Terashi-Suzuki, Tomoko Takai, Ayumi Kanno, Maki Koyanagi-Kimura, Tomokazu Matsuda, Naoko Hashimoto & Yoshiaki Kido. (2017) Histone deacetylase regulates insulin signaling via two pathways in pancreatic β cells. PLOS ONE 12:9, pages e0184435.
Crossref
Michael Yoon Kang, Joey Yeoh, Ashwini Pondicherry, Habib Rahman & Ajith Dissanayake. (2017) Insulinoma and Tuberous Sclerosis: A Possible Mechanistic Target of Rapamycin (mTOR) Pathway Abnormality?. Journal of the Endocrine Society 1:9, pages 1120-1123.
Crossref
Ayako Uchinaka, Mamoru Yoneda, Yuichiro Yamada, Toyoaki Murohara & Kohzo Nagata. (2017) Effects of mTOR inhibition on cardiac and adipose tissue pathology and glucose metabolism in rats with metabolic syndrome. Pharmacology Research & Perspectives 5:4, pages e00331.
Crossref
Kathrin Maedler & Amin Ardestani. (2017) mTORC in β cells: more Than Only Recognizing Comestibles. Journal of Cell Biology 216:7, pages 1883-1885.
Crossref
Tomohiro Suhara, Yuichi Baba, Briana K. Shimada, Jason K. Higa & Takashi Matsui. (2017) The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus. Current Diabetes Reports 17:6.
Crossref
Avileen Kaur & Saurabh Sharma. (2017) Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases. Inflammopharmacology 25:3, pages 293-312.
Crossref
Ting Yuan, Sahar Rafizadeh, Kanaka Durga Devi Gorrepati, Blaz Lupse, Jose Oberholzer, Kathrin Maedler & Amin Ardestani. (2016) Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes. Diabetologia 60:4, pages 668-678.
Crossref
Robert A. Saxton & David M. Sabatini. (2017) mTOR Signaling in Growth, Metabolism, and Disease. Cell 168:6, pages 960-976.
Crossref
Yoshiaki Kido. (2016) Gene–environment interaction in type 2 diabetes. Diabetology International 8:1, pages 7-13.
Crossref
Jeddidiah W. D. Griffin & Patrick C. Bradshaw. (2017) Amino Acid Catabolism in Alzheimer’s Disease Brain: Friend or Foe?. Oxidative Medicine and Cellular Longevity 2017, pages 1-15.
Crossref
Ana García-Aguilar, Carlos Guillén, Mark Nellist, Alberto Bartolomé & Manuel Benito. (2016) TSC2 N-terminal lysine acetylation status affects to its stability modulating mTORC1 signaling and autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863:11, pages 2658-2667.
Crossref
E Bucris, A Beck, S Boura-Halfon, R Isaac, Y Vinik, T Rosenzweig, S R Sampson & Y Zick. (2016) Prolonged insulin treatment sensitizes apoptosis pathways in pancreatic β cells. Journal of Endocrinology 230:3, pages 291-307.
Crossref
Manuel Blandino-Rosano, Joshua O. Scheys, Margarita Jimenez-Palomares, Rebecca Barbaresso, Aaron S. Bender, Akiko Yanagiya, Ming Liu, Liangyou Rui, Nahum Sonenberg & Ernesto Bernal-Mizrachi. (2016) 4E-BP2/SH2B1/IRS2 Are Part of a Novel Feedback Loop That Controls β-Cell Mass. Diabetes 65:8, pages 2235-2248.
Crossref
Jing Wang, Xin Yang & Jingjing Zhang. (2016) Bridges between mitochondrial oxidative stress, ER stress and mTOR signaling in pancreatic β cells. Cellular Signalling 28:8, pages 1099-1104.
Crossref
Rachel E. Stamateris, Rohit B. Sharma, Yahui Kong, Pantea Ebrahimpour, Deepika Panday, Pavana Ranganath, Baobo Zou, Helena Levitt, Nisha Abraham Parambil, Christopher P. O’Donnell, Adolfo García-Ocaña & Laura C. Alonso. (2016) Glucose Induces Mouse β-Cell Proliferation via IRS2, MTOR, and Cyclin D2 but Not the Insulin Receptor. Diabetes 65:4, pages 981-995.
Crossref
Qi Cheng, Violeta D Beltran, Stanley M H Chan, Jeremy R Brown, Alan Bevington & Terence P Herbert. (2016) System-L amino acid transporters play a key role in pancreatic β-cell signalling and function. Journal of Molecular Endocrinology 56:3, pages 175-187.
Crossref
Lucia E. RamehJude T. Deeney. (2016) Phosphoinositide signalling in type 2 diabetes: a β-cell perspective. Biochemical Society Transactions 44:1, pages 293-298.
Crossref
Marta M. Swierczynska & Michael N. Hall. 2016. Molecules to Medicine with mTOR. Molecules to Medicine with mTOR 347 364 .
Katherine H. Schreiber, Monique N. O’Leary & Brian K. Kennedy. 2016. Handbook of the Biology of Aging. Handbook of the Biology of Aging 55 81 .
Hala Elnakat Thomas, Sónia R. Pereira da Veiga, George Thomas & Sara C. Kozma. 2016. mTOR Inhibition for Cancer Therapy: Past, Present and Future. mTOR Inhibition for Cancer Therapy: Past, Present and Future 19 45 .
Bo Kong, Tao Cheng, Chengjia Qian, Weiwei Wu, Katja Steiger, Jing Cao, Anna Melissa Schlitter, Ivonne Regel, Susanne Raulefs, Helmut Friess, Mert Erkan, Irene Esposito, Jörg Kleeff & Christoph W. Michalski. (2015) Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma. Molecular Cancer 14:1.
Crossref
Bruno Vergès & Bertrand Cariou. (2015) mTOR inhibitors and diabetes. Diabetes Research and Clinical Practice 110:2, pages 101-108.
Crossref
Avital Swisa, Zvi Granot, Natalia Tamarina, Sophie Sayers, Nabeel Bardeesy, Louis Philipson, David J. Hodson, Jakob D. Wikstrom, Guy A. Rutter, Gil Leibowitz, Benjamin Glaser & Yuval Dor. (2015) Loss of Liver Kinase B1 (LKB1) in Beta Cells Enhances Glucose-stimulated Insulin Secretion Despite Profound Mitochondrial Defects. Journal of Biological Chemistry 290:34, pages 20934-20946.
Crossref
Bodo Melnik. (2015) Milk—A Nutrient System of Mammalian Evolution Promoting mTORC1-Dependent Translation. International Journal of Molecular Sciences 16:8, pages 17048-17087.
Crossref
Shun-ichiro AsaharaHiroaki EtohHiroyuki InoueKyoko TeruyamaYuki ShibutaniYuka IharaYukina KawadaAlberto BartolomeNaoko HashimotoTomokazu MatsudaMaki Koyanagi-KimuraAyumi KannoYushi HirotaTetsuya HosookaKazuaki NagashimaWataru NishimuraHiroshi InoueMichihiro MatsumotoMichael J. HigginsKazuki YasudaNobuya InagakiSusumu SeinoMasato Kasuga & Yoshiaki Kido. (2015) Paternal allelic mutation at the Kcnq1 locus reduces pancreatic β-cell mass by epigenetic modification of Cdkn1c . Proceedings of the National Academy of Sciences 112:27, pages 8332-8337.
Crossref
B. Vergès. (2015) Diabète secondaire aux inhibiteurs mTOR. Médecine des Maladies Métaboliques 9:3, pages 255-259.
Crossref
Robin M Hobbs, Hue M La, Juho‐Antti Mäkelä, Toshiyuki Kobayashi, Tetsuo Noda & Pier Paolo Pandolfi. (2015) Distinct germline progenitor subsets defined through Tsc2– mTORC 1 signaling . EMBO reports 16:4, pages 467-480.
Crossref
Ayumi Kanno, Shun-ichiro Asahara, Katsuhisa Masuda, Tomokazu Matsuda, Maki Kimura-Koyanagi, Susumu Seino, Wataru Ogawa & Yoshiaki Kido. (2015) Compensatory hyperinsulinemia in high-fat diet-induced obese mice is associated with enhanced insulin translation in islets. Biochemical and Biophysical Research Communications 458:3, pages 681-686.
Crossref
M V Blagosklonny. (2014) Koschei the immortal and anti-aging drugs. Cell Death & Disease 5:12, pages e1552-e1552.
Crossref
Alberto Bartolomé, Maki Kimura-Koyanagi, Shun-Ichiro Asahara, Carlos Guillén, Hiroyuki Inoue, Kyoko Teruyama, Shinobu Shimizu, Ayumi Kanno, Ana García-Aguilar, Masato Koike, Yasuo Uchiyama, Manuel Benito, Tetsuo Noda & Yoshiaki Kido. (2014) Pancreatic β-Cell Failure Mediated by mTORC1 Hyperactivity and Autophagic Impairment. Diabetes 63:9, pages 2996-3008.
Crossref
O V Leontieva, Z N Demidenko & M V Blagosklonny. (2014) Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium. Cell Death & Disease 5:5, pages e1214-e1214.
Crossref
Yuri Yoshida, Megumi Fuchita, Maki Kimura-Koyanagi, Ayumi Kanno, Tomokazu Matsuda, Shun-ichiro Asahara, Naoko Hashimoto, Takayuki Isagawa, Wataru Ogawa, Hiroyuki Aburatani, Tetsuo Noda, Susumu Seino, Masato Kasuga & Yoshiaki Kido. (2013) Contribution of insulin signaling to the regulation of pancreatic beta-cell mass during the catch-up growth period in a low birth weight mouse model. Diabetology International 5:1, pages 43-52.
Crossref
Bruno Vergès, Thomas Walter & Bertrand Cariou. (2014) ENDOCRINE SIDE EFFECTS OF ANTI-CANCER DRUGS: Effects of anti-cancer targeted therapies on lipid and glucose metabolism. European Journal of Endocrinology 170:2, pages R43-R55.
Crossref
Kai-Ting Yang, Jennifer-Ann Bayan, Ni Zeng, Richa Aggarwal, Lina He, Zhechu Peng, Anketse Kassa, Melissa Kim, Zhiou Luo, Zhenrong Shi, Vivian Medina, Keerthi Boddupally & Bangyan L. Stiles. (2013) Adult-onset deletion of Pten increases islet mass and beta cell proliferation in mice. Diabetologia 57:2, pages 352-361.
Crossref
Alberto Bartolome & Carlos Guillén. 2014. The Pancreatic Beta Cell. The Pancreatic Beta Cell 425 469 .
M V Blagosklonny. (2013) TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists. Cell Death & Disease 4:12, pages e964-e964.
Crossref
Jia NieXiaolei LiuBrendan N. Lilley, Hai Zhang, Y. Albert Pan, Scot R. KimballJun ZhangWeiping Zhang, Li WangLeonard S. JeffersonJoshua R. Sanes, Xiao HanYuguang Shi. (2013) SAD-A kinase controls islet β-cell size and function as a mediator of mTORC1 signaling. Proceedings of the National Academy of Sciences 110:34, pages 13857-13862.
Crossref
Adam D. BarlowMichael L. NicholsonTerry P. Herbert. (2013) Evidence for Rapamycin Toxicity in Pancreatic β-Cells and a Review of the Underlying Molecular Mechanisms. Diabetes 62:8, pages 2674-2682.
Crossref
Mahasin A. Osman, Fazlul H. Sarkar & Enrique Rodriguez-Boulan. (2013) A molecular rheostat at the interface of cancer and diabetes. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1836:1, pages 166-176.
Crossref
S. Asahara, Y. Shibutani, K. Teruyama, H. Y. Inoue, Y. Kawada, H. Etoh, T. Matsuda, M. Kimura-Koyanagi, N. Hashimoto, M. Sakahara, W. Fujimoto, H. Takahashi, S. Ueda, T. Hosooka, T. Satoh, H. Inoue, M. Matsumoto, A. Aiba, M. Kasuga & Y. Kido. (2013) Ras-related C3 botulinum toxin substrate 1 (RAC1) regulates glucose-stimulated insulin secretion via modulation of F-actin. Diabetologia 56:5, pages 1088-1097.
Crossref
Christine Longuet, Ana M. Robledo, E. Danielle Dean, Chunhua Dai, Safina Ali, Ian McGuinness, Vincent de Chavez, Patricia M. Vuguin, Maureen J. Charron, Alvin C. PowersDaniel J. Drucker. (2013) Liver-Specific Disruption of the Murine Glucagon Receptor Produces α-Cell Hyperplasia. Diabetes 62:4, pages 1196-1205.
Crossref
Accalia Fu, Chandra E. Eberhard & Robert A. Screaton. (2013) Role of AMPK in pancreatic beta cell function. Molecular and Cellular Endocrinology 366:2, pages 127-134.
Crossref
Olivier Le Bacquer, Gurvan Queniat, Valery Gmyr, Julie Kerr-Conte, Bruno Lefebvre & François Pattou. (2013) mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Journal of Endocrinology 216:1, pages 21-29.
Crossref
Colleen Carkeet, Kerry Grann, R Randolph, Dawna Venzon & Samantha IzzyJacob Junco & Thomas Slaga. 2012. Phytochemicals. Phytochemicals 113 152 .
Rohit N. Kulkarni, Ernesto-Bernal Mizrachi, Adolfo Garcia Ocana & Andrew F. Stewart. (2012) Human β-Cell Proliferation and Intracellular Signaling. Diabetes 61:9, pages 2205-2213.
Crossref
Inan Bakan & Mathieu Laplante. (2012) Connecting mTORC1 signaling to SREBP-1 activation. Current Opinion in Lipidology 23:3, pages 226-234.
Crossref
A. D. Barlow, J. Xie, C. E. Moore, S. C. Campbell, J. A. M. Shaw, M. L. Nicholson & T. P. Herbert. (2012) Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2). Diabetologia 55:5, pages 1355-1365.
Crossref
Mathieu Laplante & David M. Sabatini. (2012) mTOR Signaling in Growth Control and Disease. Cell 149:2, pages 274-293.
Crossref
Jianling Xie & Terence P. Herbert. (2011) The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes. Cellular and Molecular Life Sciences 69:8, pages 1289-1304.
Crossref
Bodo C Melnik. (2012) Leucine signaling in the pathogenesis of type 2 diabetes and obesity. World Journal of Diabetes 3:3, pages 38.
Crossref
Hiroyuki Mori & Kun-Liang Guan. 2012. mTOR. mTOR 407 419 .
Maki Koyanagi, Shun-ichiro Asahara, Tomokazu Matsuda, Naoko Hashimoto, Yutaka Shigeyama, Yuki Shibutani, Ayumi Kanno, Megumi Fuchita, Tomoko Mikami, Tetsutya Hosooka, Hiroshi Inoue, Michihiro Matsumoto, Masato Koike, Yasuo Uchiyama, Tetsuo Noda, Susumu Seino, Masato Kasuga & Yoshiaki Kido. (2011) Ablation of TSC2 Enhances Insulin Secretion by Increasing the Number of Mitochondria through Activation of mTORC1. PLoS ONE 6:8, pages e23238.
Crossref
Hirotomo Sasaki, Hisafumi Yasuda, Hiroaki Moriyama, Akira Nakamura, Mami Shimizu, Takashi Arai, Masao Nagata, Kenta Hara & Koichi Yokono. (2011) Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation. Biochemical and Biophysical Research Communications 408:2, pages 306-311.
Crossref
Jessica J. Howell & Brendan D. Manning. (2011) mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends in Endocrinology & Metabolism 22:3, pages 94-102.
Crossref
Sean Oldham. (2011) Obesity and nutrient sensing TOR pathway in flies and vertebrates: Functional conservation of genetic mechanisms. Trends in Endocrinology & Metabolism 22:2, pages 45-52.
Crossref
Nissim Hay. (2011) Akt isoforms and glucose homeostasis – the leptin connection. Trends in Endocrinology & Metabolism 22:2, pages 66-73.
Crossref
Lynda ElghaziNorman BalcazarManuel Blandino-RosanoCorentin Cras-MéneurSzabolcs FatraiAaron P. GouldMaggie M. ChiKelle H. MoleyErnesto Bernal-Mizrachi. (2010) Decreased IRS Signaling Impairs β-Cell Cycle Progression and Survival in Transgenic Mice Overexpressing S6K in β-Cells. Diabetes 59:10, pages 2390-2399.
Crossref
Alberto Bartolomé, Carlos Guillén & Manuel Benito. (2010) Role of the TSC1-TSC2 Complex in the Integration of Insulin and Glucose Signaling Involved in Pancreatic β-Cell Proliferation. Endocrinology 151:7, pages 3084-3094.
Crossref
David J. Kwiatkowski. 2010. Tuberous Sclerosis Complex. Tuberous Sclerosis Complex 117 143 .
David J. Kwiatkowski. (2010) Animal Models of Lymphangioleiomyomatosis (LAM) and Tuberous Sclerosis Complex (TSC). Lymphatic Research and Biology 8:1, pages 51-57.
Crossref
Marion Cornu & Michael N. Hall. 2010. Structure, Function and Regulation of Tor Complexes from Yeasts to Mammals Part B. Structure, Function and Regulation of Tor Complexes from Yeasts to Mammals Part B 263 278 .
Hiroyuki MoriKen InokiDarren OplandHeike MünzbergEneida C. VillanuevaMiro FaouziTsuneo IkenoueDavid J. Kwiatkowski, Ormond A. MacDougaldMartin G. MyersJr.Jr. & Kun-Liang Guan. (2009) Critical roles for the TSC-mTOR pathway in β-cell function. American Journal of Physiology-Endocrinology and Metabolism 297:5, pages E1013-E1022.
Crossref
Kristen Pollizzi, Izabela Malinowska-Kolodziej, Cheryl Doughty, Charles Betz, Jian Ma, June Goto & David J. Kwiatkowski. (2009) A hypomorphic allele of Tsc2 highlights the role of TSC1/TSC2 in signaling to AKT and models mild human TSC2 alleles. Human Molecular Genetics 18:13, pages 2378-2387.
Crossref
Lynda Elghazi & Ernesto Bernal-Mizrachi. (2009) Akt and PTEN: β-cell mass and pancreas plasticity. Trends in Endocrinology & Metabolism 20:5, pages 243-251.
Crossref
Suirin HamadaKenta HaraTakeshi HamadaHisafumi YasudaHiroaki MoriyamaRika NakayamaMasao NagataKoichi Yokono. (2009) Upregulation of the Mammalian Target of Rapamycin Complex 1 Pathway by Ras Homolog Enriched in Brain in Pancreatic β-Cells Leads to Increased β-Cell Mass and Prevention of Hyperglycemia. Diabetes 58:6, pages 1321-1332.
Crossref
K. Inoki & K.-L. Guan. (2009) Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. Human Molecular Genetics 18:R1, pages R94-R100.
Crossref
Hiroyuki Mori, Ken Inoki, Heike Münzberg, Darren Opland, Miro Faouzi, Eneida C. Villanueva, Tsuneo Ikenoue, David Kwiatkowski, Ormond A. MacDougald, Martin G. MyersJr.Jr. & Kun-Liang Guan. (2009) Critical Role for Hypothalamic mTOR Activity in Energy Balance. Cell Metabolism 9:4, pages 362-374.
Crossref
Pazit Polak & Michael N Hall. (2009) mTOR and the control of whole body metabolism. Current Opinion in Cell Biology 21:2, pages 209-218.
Crossref
Shun-ichiro Asahara, Tomokazu Matsuda, Yoshiaki Kido & Masato Kasuga. (2009) Increased ribosomal biogenesis induces pancreatic β cell failure in mice model of type 2 diabetes. Biochemical and Biophysical Research Communications 381:3, pages 367-371.
Crossref
Etti Bachar, Yafa Ariav, Mali Ketzinel-Gilad, Erol Cerasi, Nurit Kaiser & Gil Leibowitz. (2009) Glucose Amplifies Fatty Acid-Induced Endoplasmic Reticulum Stress in Pancreatic β-Cells via Activation of mTORC1. PLoS ONE 4:3, pages e4954.
Crossref
Norman Balcazar, Aruna Sathyamurthy, Lynda Elghazi, Aaron Gould, Aaron Weiss, Ichiro Shiojima, Kenneth Walsh & Ernesto Bernal-Mizrachi. (2009) mTORC1 Activation Regulates β-Cell Mass and Proliferation by Modulation of Cyclin D2 Synthesis and Stability. Journal of Biological Chemistry 284:12, pages 7832-7842.
Crossref
Tae Inoue, Yoshiaki Kido, Shun-ichiro Asahara, Tomokazu Matsuda, Yuki Shibutani, Maki Koyanagi & Masato Kasuga. (2009) Effect of intrauterine undernutrition during late gestation on pancreatic β cell mass. Biomedical Research 30:6, pages 325-330.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.